Last update 08 Nov 2024
MT-2990
Last update 08 Nov 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms MT 2990 |
Target |
Mechanism IL-33 inhibitors(Interleukin-33 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with MT-2990An Exploratory Study of MT-2990 in Patients With Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of MT-2990 in Women With Endometriosis Experiencing Endometrial Related Pain
A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients (Single Dose Study)
100 Clinical Results associated with MT-2990
Login to view more data
100 Translational Medicine associated with MT-2990
Login to view more data
100 Patents (Medical) associated with MT-2990
Login to view more data
100 Deals associated with MT-2990
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Endometriosis | Phase 2 | US | 15 Jan 2019 | |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Phase 1 | JP | 24 Jun 2024 | |
| Rhinitis, Allergic, Seasonal | Phase 1 | JP | 17 Jul 2018 | |
| Inflammation | Phase 1 | NL | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 76 | Placebo (Placebo) | hwdszxfasa(dhoievceto) = fulnhrjciy hhrmyvjjio (jmgxalwlwl, divlgdwluv - cjyipwlrfn) View more | - | 10 Jul 2024 | ||
(MT-2990) | hwdszxfasa(dhoievceto) = zhptqzesfe hhrmyvjjio (jmgxalwlwl, fuyziervhy - xgwyagqyom) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free